Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1081.15
(2.68%)
INR 1081.15
(2.68%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.12 Billion INR | -44.71% |
| 2022 | 7.45 Billion INR | 1.49% |
| 2021 | 7.34 Billion INR | 31.26% |
| 2020 | 5.59 Billion INR | 15.59% |
| 2019 | 4.84 Billion INR | 125.16% |
| 2018 | 2.15 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 809.9 Million INR | 6.52% |
| 2023 Q2 | 1.44 Billion INR | -32.63% |
| 2023 Q4 | 760.36 Million INR | -33.7% |
| 2023 FY | 4.12 Billion INR | -44.71% |
| 2023 Q3 | 1.14 Billion INR | -20.46% |
| 2023 Q1 | 2.14 Billion INR | 5.3% |
| 2022 Q3 | 1.96 Billion INR | 34.51% |
| 2022 Q1 | 1.99 Billion INR | 1.76% |
| 2022 FY | 7.45 Billion INR | 1.49% |
| 2022 Q4 | 2.03 Billion INR | 3.29% |
| 2022 Q2 | 1.46 Billion INR | -26.64% |
| 2021 Q1 | 1.48 Billion INR | 36.13% |
| 2021 FY | 7.34 Billion INR | 31.26% |
| 2021 Q4 | 1.95 Billion INR | -13.25% |
| 2021 Q3 | 2.25 Billion INR | 37.17% |
| 2021 Q2 | 1.64 Billion INR | 11.11% |
| 2020 Q4 | 1.08 Billion INR | -37.15% |
| 2020 Q3 | 1.73 Billion INR | 29.2% |
| 2020 Q2 | 1.34 Billion INR | -6.64% |
| 2020 FY | 5.59 Billion INR | 15.59% |
| 2020 Q1 | 1.43 Billion INR | 61.62% |
| 2019 Q2 | 1.55 Billion INR | 18.54% |
| 2019 FY | 4.84 Billion INR | 125.16% |
| 2019 Q3 | 1.07 Billion INR | -30.73% |
| 2019 Q4 | 888.46 Million INR | -17.47% |
| 2019 Q1 | 1.31 Billion INR | -8.04% |
| 2018 Q4 | 1.42 Billion INR | 96.59% |
| 2018 Q3 | 725.14 Million INR | 0.0% |
| 2018 FY | 2.15 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 84.604% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 97.334% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 66.836% |
| Granules India Limited | 16.79 Billion INR | 75.456% |
| Indoco Remedies Limited | 6.04 Billion INR | 31.749% |
| Achyut Healthcare Limited | 4.86 Million INR | -84723.575% |
| Ajanta Pharma Limited | 21.06 Billion INR | 80.425% |
| Alkem Laboratories Limited | 52.29 Billion INR | 92.116% |
| Alpa Laboratories Limited | 188.89 Million INR | -2082.839% |
| Brooks Laboratories Limited | 65.62 Million INR | -6183.563% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 33.738% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -180.151% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -11.578% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 97.48% |
| Eris Lifesciences Limited | 10.42 Billion INR | 60.455% |
| FDC Limited | 8.33 Billion INR | 50.529% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 94.054% |
| Gufic Biosciences Limited | 4.16 Billion INR | 1.066% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 33.435% |
| Ipca Laboratories Limited | 29.8 Billion INR | 86.168% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -531.832% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -2039.438% |
| Lasa Supergenerics Limited | 121.02 Million INR | -3306.82% |
| Laurus Labs Limited | 24.62 Billion INR | 83.252% |
| Lupin Limited | 123.71 Billion INR | 96.667% |
| Mankind Pharma Limited | 44.52 Billion INR | 90.739% |
| Medicamen Biotech Limited | 495.49 Million INR | -732.152% |
| Medico Remedies Limited | 262.14 Million INR | -1472.904% |
| Megasoft Limited | 342.07 Million INR | -1105.385% |
| NATCO Pharma Limited | 25.73 Billion INR | 83.979% |
| Piramal Pharma Limited | 24.47 Billion INR | 83.15% |
| RPG Life Sciences Limited | 2.48 Billion INR | -66.06% |
| Sigachi Industries Limited | 2 Billion INR | -105.929% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.405% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -337.53% |
| Unichem Laboratories Limited | 4.86 Billion INR | 15.245% |
| Wanbury Limited | 1.73 Billion INR | -138.251% |
| Windlas Biotech Limited | 1.33 Billion INR | -207.983% |
| ZIM Laboratories Limited | 1.26 Billion INR | -225.465% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 96.707% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 784.468% |
| Divi's Laboratories Limited | 32.44 Billion INR | 87.29% |
| Hester Biosciences Limited | 1.27 Billion INR | -223.737% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 28.68% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -164.901% |
| Bal Pharma Limited | 770.19 Million INR | -435.355% |
| Strides Pharma Science Limited | 14.38 Billion INR | 71.342% |
| Venus Remedies Limited | 2.18 Billion INR | -88.917% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 29.291% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -38.735% |
| Shilpa Medicare Limited | 3.54 Billion INR | -16.251% |
| Aarti Drugs Limited | 8.31 Billion INR | 50.419% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | 9.988% |
| Suven Life Sciences Limited | -200.79 Million INR | 2153.454% |
| Ind-Swift Limited | 2.17 Billion INR | -89.791% |
| Valiant Laboratories Limited | -60.66 Million INR | 6896.904% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 81.836% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -378.782% |
| Themis Medicare Limited | 1.5 Billion INR | -174.171% |
| Hikal Limited | 3.14 Billion INR | -31.186% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 91.182% |
| Sequent Scientific Limited | 2.97 Billion INR | -38.424% |
| Novartis India Limited | 1.32 Billion INR | -210.745% |
| Wockhardt Limited | 16.24 Billion INR | 74.61% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 79.009% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -28180.925% |
| Neuland Laboratories Limited | 8.24 Billion INR | 50.008% |
| Morepen Laboratories Limited | 6.16 Billion INR | 33.078% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -564.533% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -486.021% |